Relmada Therapeutics Inc DCF Valuation - Relmada Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 5.65 EUR -1.74%

Market Cap: €170.1m

	Relmada Therapeutics Inc F:4E2	US
L	Lynas Rare Earths Ltd F:LYIC	MY
C	Campbell Soup Co F:CSC	US
C	Compagnie de Saint Gobain SA XBER:GOB	FR
	Silvercrest Asset Management Group Inc NASDAQ:SAMG	US
C	Cintas Corp DUS:CIT	US
	Thungela Resources Ltd OTC:TNGRF	ZA
	Barratt Developments P L C OTC:BTDPF	UK
M	Macy's Inc XETRA:FDO	US

Relmada Therapeutics Inc's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

Continue Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

NASDAQ • USD

RLMD

Join 344,800+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.